Determination of piroxicam and its major metabolites in the plasma, urine and bile of humans by high-performance liquid chromatography

J Chromatogr. 1992 Apr 15;576(1):121-8. doi: 10.1016/0378-4347(92)80182-p.

Abstract

A simple and sensitive liquid chromatographic method with ultraviolet detection is described for the determination of the nonsteroidal anti-inflammatory drug piroxicam and its major metabolites in human plasma, urine and bile. Separation of these components occurs on a reversed phase C10CN column with a mobile phase consisting of acetonitrile-water-sodium dihydrogenphosphate solution. The detection limit of the assay was 50 ng/ml with intra- and inter-assay coefficients of variation for piroxicam of the order of 2 and 5%, respectively. The assay linearity was good (typically r = 0.9999). This method can be readily utilised for clinical pharmacokinetic and mass-balance studies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Bile / chemistry*
  • Chromatography, High Pressure Liquid
  • Female
  • Humans
  • Indicators and Reagents
  • Piroxicam / analogs & derivatives
  • Piroxicam / analysis*
  • Piroxicam / blood
  • Piroxicam / pharmacokinetics
  • Piroxicam / urine

Substances

  • Indicators and Reagents
  • Piroxicam
  • 5'-hydroxypiroxicam